ENTRY       D11435                      Drug
NAME        Nimacimab (USAN)
FORMULA     C6440H9914N1714O2014S44
EXACT_MASS  144893.3754
MOL_WEIGHT  144982.7606
SEQUENCE    (Heavy chain)
            QVQLVQSGAE VKKPGSSVKV SCKASGYEFS YYWMNWVRQA PGQGLEWMGQ IYPGDGETKY
            AQKFQGRVTI TADKSTSTAY MELSSLRSED TAVYYCARSH GNYLPYWGQG TLVTVSSAST
            KGPSVFPLAP CSRSTSESTA ALGCLVKDYF PEPVTVSWNS GALTSGVHTF PAVLQSSGLY
            SLSSVVTVPS SSLGTKTYTC NVDHKPSNTK VDKRVESKYG PPCPPCPAPE FLGGPSVFLF
            PPKPKDTLMI SRTPEVTCVV VDVSQEDPEV QFNWYVDGVE VHNAKTKPRE EQFNSTYRVV
            SVLTVLHQDW LNGKEYKCKV SNKGLPSSIE KTISKAKGQP REPQVYTLPP SQEEMTKNQV
            SLTCLVKGFY PSDIAVEWES NGQPENNYKT TPPVLDSDGS FFLYSRLTVD KSRWQEGNVF
            SCSVMHEALH NHYTQKSLSL SLGK
            (Light chain)
            EIVLTQSPAT LSLSPGERAT LSCRASQSVS SSYLHWYQQK PGQAPRLLIY STSNLASGIP
            ARFSGSGSGT DFTLTISRLE PEDFAVYYCH QYHRSPPTFG QGTKVEIKRT VAAPSVFIFP
            PSDEQLKSGT ASVVCLLNNF YPREAKVQWK VDNALQSGNS QESVTEQDSK DSTYSLSSTL
            TLSKADYEKH KVYACEVTHQ GLSSPVTKSF NRGEC
            (Disulfide bridge: H22-H96, H131-L215, H144-H200, H223-H'223, H226-H'226, H258-H318, H364-H422, H'22-H'96, H'131-L'215, H'144-H'200, H'258-H'318, H'364-H'422, L23-L89, L135-L195, L'23-L'89, L'135-L'195)
  TYPE      Peptide
EFFICACY    Anti-inflammatory
  TYPE      Monoclonal antibody
COMMENT     Treatment of non-alcoholic steatohepatitis (NASH) and other cardiometabolic diseases associated with dysregulation of the endocannabinoid system (ECS)
TARGET      CNR1 [HSA:1268] [KO:K04277]
  PATHWAY   hsa04080(1268)  Neuroactive ligand-receptor interaction
            hsa04723(1268)  Retrograde endocannabinoid signaling
BRITE       Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Cannabinoid
                CNR1
                 D11435  Nimacimab (USAN)
DBLINKS     CAS: 2098636-09-8
            PubChem: 384585412
///
